Combined Therapy of Arterial Hypertension. The Opinion of a Clinical Pharmacologist
Open Access
- 2 September 2020
- journal article
- research article
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 16 (4), 601-606
- https://doi.org/10.20996/1819-6446-2020-08-12
Abstract
Modern tactics of treatment of arterial hypertension (AH) involves the use of both monotherapy and combination therapy. Monotherapy is recommended primarily for low-risk patients with systolic blood pressure (BP)< 150 mm Hg. Monotherapy should also be preferred in very high risk patients with high normal BP and frail elderly patients. However, combination therapy is recommended for most hypertensive patients as initial therapy. Starting combination therapy is more effective in lowering BP than monotherapy. Even at low doses, it is usually more effective than maximum dose monotherapy. The most commonly prescribed combinations today contain a renin-angiotensin system blocker (angiotensin converting enzyme inhibitors or angiotensin II receptor blocker) with a calcium antagonist or diuretic. The combination of lisinopril with amlodipine not only proved its high efficiency in various international and Russian studies, but also turned out to be pharmacoeconomically more profitable. Fixed combinations of lisinopril and amlodipine are the optimal choice in the treatment of hypertensive patients, due to all the advantages of both components: higher efficacy and safety rates compared to monotherapy and better patient adherence to treatment.Keywords
This publication has 29 references indexed in Scilit:
- Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort studyBMJ, 2015
- Cardiorenal End Points in a Trial of Aliskiren for Type 2 DiabetesThe New England Journal of Medicine, 2012
- Initial Monotherapy and Combination Therapy and Hypertension Control the First YearHypertension, 2012
- Prevention of cardiovascular events with calcium channel blocker-based combination therapies in patients with hypertensionJournal of Hypertension, 2011
- Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practiceJournal of Hypertension, 2010
- Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive AgentsHypertension, 2010
- Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 TrialsThe American Journal of Medicine, 2009
- Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk PatientsThe New England Journal of Medicine, 2008
- Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes: Principal Results of the Conduit Artery Function Evaluation (CAFE) StudyYearbook of Cardiology, 2007
- Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialThe Lancet, 2005